Inflammation

Items 1321-1330 of 1366

per page
Set Descending Direction
  1. SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (P.1 Variant, Gamma)
    AG-40B-0204
    AG-40B-0204-C05050 µg
    CHF 330.00
    AG-40B-0204-30503 x 50 µg
    CHF 660.00
    SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (P.1 Variant, Gamma)
  2. SCF (human):Fc (human) (rec.)
    CHI-HF-210SCF
    CHI-HF-210SCF-C01010 µg
    CHF 190.00
  3. SCF (human):Fc (human) (rec.) (non-lytic)
    CHI-HF-220SCF
    CHI-HF-220SCF-C05050 µg
    CHF 320.00
  4. SCF (human):Fc (mouse) (rec.)
    CHI-HF-211SCF
    CHI-HF-211SCF-C05050 µg
    CHF 320.00
  5. SDF-1α [CXCL12] (human):Fc (human) (rec.)
    CHI-HF-210SDF1A
    CHI-HF-210SDF1A-C05050 µg
    CHF 370.00
  6. SIGIRR (human):Fc (human) (rec.)
    AG-40A-0093T
    AG-40A-0093T-C01010 µg
    CHF 170.00
    AG-40A-0093T-C05050 µg
    CHF 350.00
  7. ST2 (human):Fc (human) (rec.)
    AG-40A-0059
    AG-40A-0059-C05050 µg
    CHF 505.00
    Specific interaction of human ST2 (Prod. No. AG-40A-0059) with recombinant human IL-33. An indirect competitive ELISA was performed as follows; 1) coat microtiter plate wells with hST2-Fc (10μg/ml); 2) add a varying concentrations of hIL-33 with
  8. SUMO1 (human) (rec.) (Rhodamine 110)
    SBB-PS0028
    SBB-PS0028-C05050 µg
    CHF 434.00
    Signal to Background: The signal to background ratio was determined by 100% hydrolysis of 200nM, 100nM, 50nM SUMO1-Rhodamine 110 to liberate the quenched conjugate. Assay Buffer: 50mM HEPES pH 7.5, 1mM TCEP, 0.1mg/ml BSA.
  9. SUMO2 (human) (rec.) (Rhodamine 110)
    SBB-PS0029
    SBB-PS0029-C05050 µg
    CHF 434.00
    Signal to Background: The signal to background ratio was determined by 100% hydrolysis of 200nM, 100nM, 50nM SUMO2-Rhodamine 110 to liberate the quenched conjugate. Assay Buffer: 50mM HEPES pH 7.5, 1mM TCEP, 0.1mg/ml BSA.
  10. TACI (human):Fc (human) (rec.)
    AG-40B-0079
    AG-40B-0079-C05050 µg
    CHF 330.00
    AG-40B-0079-30503 x 50 µg
    CHF 660.00

Items 1321-1330 of 1366

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.